Historical record - last NADAC effective date: 7/17/2024
Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.0546 per EA under NDC 51224010760. Its NADAC has been published 418 times since Aug 17, 2016.
FDA first approved this application on Apr 17, 2008. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224010760
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078321FDA Approved
4/17/2008
TE Code
AB1
On Market Since
4/17/2008
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 418 times since Aug 17, 2016, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0546 per EA |
|---|---|
| All-time high | $0.1103 (Oct 12, 2016) |
| All-time low | $0.0546 (Jul 17, 2024) |
| Median price | $0.0706 |
| Average price | $0.0738 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 418 |
| Tracking since | Aug 17, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-16.7%
5Y
-38.6%
All
-49.8%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by TAGI Pharma Inc., is $0.0546 per EA (NDC 51224010760), effective Aug 14, 2024.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 49.8%. It has been tracked across 418 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Aug 17, 2016, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0546 (Jul 17, 2024) to a high of $0.1103 (Oct 12, 2016), with a median of $0.0706 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0542 per EA — about 1% below METFORMIN HCL ER 750 MG TABLET.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 51224010760) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.